REVXF.US Revenio Group Oyj

Healthcare Medical Devices USA Stocks
13.55 USD
Close of Nov 18, 2026
13.54 28.50
Market cap
USD 570M
P/E
23.8x
P/B
3.48x
ROE
5.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is REVXF.US undervalued?

Graham number
Price13.55
Graham value7.06
Premium91.8%

REVXF.US trades 91.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Revenio Group Oyj fundamental analysis

No fundamental analysis for Revenio Group Oyj yet.

Revenio Group Oyj stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Sensors that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or eme…

Full company profile